Cargando…
Quantifying the Economic and Clinical Value of Reducing Antimicrobial Resistance in Gram-negative Pathogens Causing Hospital-Acquired Infections in Australia
INTRODUCTION: Antimicrobial resistance (AMR) is a global public health challenge requiring a global response to which Australia has issued a National Antimicrobial Resistance Strategy. The necessity for continued-development of new effective antimicrobials is required to tackle this immediate health...
Autores principales: | Gordon, Jason P., Al Taie, Amer, Miller, Ryan L., Dennis, James W., Blaskovich, Mark A. T., Iredell, Jonathan R., Turnidge, John D., Coombs, Geoffrey W., Grolman, David Charles, Youssef, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390426/ https://www.ncbi.nlm.nih.gov/pubmed/37341866 http://dx.doi.org/10.1007/s40121-023-00835-9 |
Ejemplares similares
-
Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan
por: Matsumoto, Tetsuya, et al.
Publicado: (2021) -
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece
por: Barmpouni, Myrto, et al.
Publicado: (2023) -
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom
por: Gordon, Jason, et al.
Publicado: (2023) -
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study
por: Matsumoto, Tetsuya, et al.
Publicado: (2022) -
Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand
por: Kongnakorn, Thitima, et al.
Publicado: (2023)